Tandem diabetes care, inc. (TNDM)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and cash equivalents

74,485

51,175

46,060

38,157

40,445

41,826

32,327

50,548

62,583

13,700

12,079

27,351

40,334

44,678

17,956

30,250

40,610

43,088

43,205

45,921

62,549

31,176

35,558

64,207

76,825

124,385

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

2,000

2,000

2,000

2,000

2,000

2,000

2,000

2,000

2,000

2,000

2,050

2,050

Short-term investments

85,723

125,283

110,887

93,231

85,159

87,201

81,254

35,957

9,295

479

459

443

3,676

8,860

16,122

24,068

27,816

28,018

38,546

51,825

53,834

36,106

44,318

30,097

33,947

5,095

Accounts receivable, net

53,962

46,585

45,325

48,438

33,027

35,193

21,689

13,914

13,043

20,793

10,582

9,029

7,687

11,172

8,198

9,426

9,093

14,055

7,006

7,473

5,226

7,652

5,842

4,362

3,423

5,299

Inventories

60,469

49,073

40,732

27,341

22,826

19,896

24,366

24,912

26,486

26,993

29,985

25,823

23,748

21,195

22,896

21,692

20,196

17,543

17,552

14,670

13,581

11,913

11,891

11,121

10,164

10,330

Prepaid and other current assets

6,234

4,025

3,594

5,989

4,571

3,769

3,035

3,012

2,936

2,191

2,887

2,487

4,489

4,187

3,814

3,445

2,852

2,280

2,614

2,170

1,960

1,904

1,438

2,634

1,947

1,830

Total current assets

280,873

276,141

246,598

213,156

186,028

187,885

162,671

128,343

114,343

64,156

55,992

65,133

79,934

92,092

70,986

90,881

102,567

106,984

110,923

124,059

139,150

90,751

101,049

114,422

128,359

148,989

Property and equipment, net

37,626

32,923

28,072

22,750

17,182

17,151

17,582

18,212

18,860

19,631

20,286

21,664

20,927

18,409

17,370

16,242

15,939

15,526

14,888

14,325

12,928

12,581

12,344

12,476

10,813

9,886

Operating lease right-of-use assets

23,014

15,561

16,577

17,665

10,087

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash - long-term

-

-

-

-

-

-

-

10,000

10,000

10,000

10,000

10,000

10,000

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

1,814

1,485

515

543

353

1,258

141

145

121

102

160

126

149

107

113

120

107

105

515

676

692

691

710

579

598

643

Total assets

343,327

326,110

292,647

255,081

214,698

206,294

181,606

157,994

144,699

95,346

87,977

98,543

112,714

112,392

90,334

109,190

120,642

124,725

128,518

141,334

155,125

106,464

116,564

130,017

142,388

162,215

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

21,783

17,745

16,314

9,268

11,206

6,824

6,198

3,646

3,751

5,150

7,605

6,624

4,890

7,513

5,607

6,841

5,974

5,234

4,018

3,999

4,087

1,949

3,046

2,520

2,053

2,352

Accrued expenses

5,896

8,014

7,978

5,786

3,376

3,930

3,931

4,278

3,199

2,832

2,536

756

2,484

1,629

2,022

2,177

2,173

2,121

2,603

1,914

2,586

2,920

1,190

1,686

1,488

1,874

Employee-related liabilities

22,059

28,320

28,207

23,896

17,047

24,030

17,229

13,641

10,510

14,488

11,413

13,121

11,630

10,183

10,536

10,952

9,538

11,761

9,854

8,677

8,789

9,722

8,367

5,497

6,574

5,876

Deferred revenue

4,377

3,869

8,187

7,139

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

5,460

4,600

3,703

2,964

2,875

2,526

2,295

3,821

3,746

5,208

9,436

1,763

1,681

1,822

1,952

1,038

803

840

638

514

382

411

Common stock warrants

25,290

23,509

23,283

25,616

29,762

17,926

20,643

12,291

18,061

5,432

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

8,320

6,320

5,951

5,341

3,703

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent-current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

368

-

Other current liabilities

11,922

11,619

10,346

7,168

6,126

8,978

6,846

5,687

5,315

5,657

5,562

6,517

6,465

6,943

7,219

5,332

5,458

5,582

3,893

2,857

2,505

2,663

2,412

2,991

2,266

4,086

Total current liabilities

99,647

99,396

100,266

84,214

76,680

66,288

58,550

42,507

43,711

36,085

29,411

30,839

29,215

31,476

34,820

27,065

24,824

26,520

22,320

18,485

18,770

18,094

15,655

13,210

13,135

14,599

Notes payable—long-term

-

-

-

-

-

-

-

77,100

76,405

76,541

75,596

74,677

73,763

78,960

44,681

44,398

44,106

29,275

29,499

29,479

29,459

29,440

29,415

29,392

29,444

29,397

Deferred rent - long-term

-

-

-

-

-

-

4,028

4,250

4,488

4,687

4,142

4,351

3,976

2,609

2,191

2,207

2,469

2,743

2,915

3,084

2,546

2,700

2,853

3,004

1,819

1,887

Operating lease liabilities - long-term

19,547

14,063

15,258

16,608

10,685

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

16,957

17,672

10,129

8,914

6,371

8,731

3,599

8,132

8,247

7,181

6,786

6,955

7,628

5,274

3,445

3,447

3,299

2,719

2,550

2,534

2,102

1,658

1,156

861

728

795

Total liabilities

136,151

131,131

125,653

109,736

93,736

75,019

66,177

131,989

132,851

124,494

115,935

116,822

114,582

118,319

85,137

77,117

74,698

61,257

57,284

53,582

52,877

51,892

49,081

46,469

45,128

46,678

Commitments and contingencies (Note 9)

-

-

-

-

-

0

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized at December 31, 2014, and 2013, no shares issued and outstanding at December 31, 2014, and 2013 respectively.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Common stock, $0.001 par value; 200,000 shares authorized, 60,071 and 59,396 shares issued and outstanding at March 31, 2020 (unaudited) and December 31, 2019, respectively.

60

59

59

58

58

57

57

53

47

10

5

50

50

3

31

31

30

3

30

30

30

24

23

23

22

23

Additional paid-in capital

847,056

819,626

794,324

769,704

743,930

731,306

719,148

595,463

521,958

448,455

438,244

431,844

426,454

398,651

394,926

391,981

387,491

384,578

380,215

377,142

372,102

303,255

297,689

293,861

288,376

284,705

Accumulated other comprehensive income (loss)

-245

122

91

162

41

-13

-13

6

-

-

-

-

-

-1

-3

3

40

20

32

37

39

8

18

12

13

-

Accumulated deficit

-639,700

-624,828

-627,500

-624,600

-623,067

-600,075

-603,763

-569,517

-510,157

-477,613

-466,207

-450,173

-428,372

-404,580

-389,757

-359,942

-341,617

-321,133

-309,043

-289,457

-269,923

-248,715

-230,248

-210,349

-191,152

-169,191

Stockholders' Equity Attributable to Parent

207,176

194,979

166,994

145,345

120,962

131,275

115,429

26,005

11,848

-29,148

-27,958

-18,279

-1,868

-5,927

5,197

32,073

45,944

63,468

71,234

87,752

102,248

54,572

67,483

83,547

97,260

115,537

Total liabilities and stockholders’ equity

343,327

326,110

292,647

255,081

214,698

206,294

181,606

157,994

144,699

95,346

87,977

98,543

112,714

112,392

90,334

109,190

120,642

124,725

128,518

141,334

155,125

106,464

116,564

130,017

142,388

162,215

Patents
Patents, net

-

-

885

967

1,048

-

1,212

1,294

1,375

1,457

-

-

-

-

-

-

-

-

-

-

-

-

2,459

2,538

2,617

-